TRT9 min read
Stopping TRT: why recovery timelines should come with uncertainty
Hormones, sperm production and symptoms can recover differently after testosterone. Learn what the main human studies can and cannot predict.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Explore the articles
Find a topic you’re curious about and take a closer look.
TRT9 min read
TRT, telehealth and the missing follow-up question
A convenient prescription is only the beginning. Learn how to assess result review, adverse-effect response, local testing and continuity in remote TRT care.
Read article
Peptides9 min read
What happens after tesamorelin stops?
Withdrawal studies show that tesamorelin’s visceral-fat reduction is not reliably permanent. Durability and a follow-up plan belong in the first conversation.
Read article
Peptides8 min read
Oxytocin in childbirth and wellness sprays: why the evidence differs
Oxytocin's established obstetric role depends on a specific product, purpose and monitoring setting. A wellness spray asks a different treatment question.
Read article
Peptides8 min read
Melanotan I and afamelanotide: why the product matters
Why an approved afamelanotide implant is not interchangeable with a tanning vial or spray, even when a label names the same peptide.
Read article
HRT9 min read
An IUD in an HRT plan: one device, different clinical jobs
The same IUD may prevent pregnancy and protect the uterine lining during HRT, but its duration must match the specific job.
Read article
Peptides8 min read
Tirzepatide and food noise: what did researchers actually measure?
A closer look at test meals, appetite scales and brain research behind claims that tirzepatide quiets food noise.
Read article
Peptides9 min read
What SS-31 injection-site reactions tell us about tolerability
Local reactions are common in elamipretide studies. Understand the trial counts, practical burden, formulation limits and distinction from serious hypersensitivity.
Read article
Peptides8 min read
Why blue color cannot prove a GHK-Cu vial's quality
Blue color cannot establish a GHK-Cu product's identity, amount or sterility. Learn what quality tests and actual recall records can tell you.
Read article
Peptides9 min read
Tesamorelin and liver fat: what the HIV trials measured
The HIV trials found less liver fat and a signal for slower fibrosis progression. They did not demonstrate that existing liver scarring was reversed.
Read article
Peptides9 min read
Tesamorelin and IGF-1: why a higher result is not the goal
IGF-1 reflects tesamorelin’s hormone effects and helps guide safety monitoring. Learn why reference ranges, clinical response, and glucose need separate attention.
Read article
Peptides9 min read
Tesamorelin versus GLP-1 trials: what the fat-loss numbers mean
Visceral-fat loss, body-weight loss and cardiovascular risk use different measurements. A closer look at tesamorelin and semaglutide trials explains the differences.
Read article206–217 of 600 articles